Maxigen Biotech Inc. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$68,526,000 NT$70,258,000
Jan-Aug Revenue NT$544,170,000 NT$521,741,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.